Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
topic_facet:"Recruitment Status: Authorised-recruitment may be ongoing or finished"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Kidney+transplant%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Kidney+transplant%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Kidney+transplant%22&type=Subject
PubPharm (16)
1
Assessment of effectiveness and safety of a 3rd dose of mRNA vaccine in kidney transplant recipients. : Assessment of association between 3rd dose of mRNA vaccine and risk of SARS-CoV-2 infection in kidney transplant recipients, safety and immunogenicity assessment.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
Assessment of effectiveness and safety of a 3rd dose of mRNA vaccine in kidney transplant recipients. : Assessment of association between 3rd dose of mRNA vaccine and risk of SARS-CoV-2 infection in kidney transplant recipients, safety and immunogenicity assessment.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
Sars-Cov2 vaccination in kidney transplant patient: a phase IV study of the immunogenicity and its determinants : COVID-19: Sars-Cov2 vaccination in kidney transplant patient: a phase IV study of the immunogenicity and its determinants - NEPHRO-VAC transplantation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Sars-Cov2 vaccination in kidney transplant patient: a phase IV study of the immunogenicity and its determinants : COVID-19: Sars-Cov2 vaccination in kidney transplant patient: a phase IV study of the immunogenicity and its determinants - NEPHRO-VAC transplantation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Preventive strategies against SARS-CoV-2 in kidney transplant recipients:Intervention A - vaccination: Study to test if vaccination with Ad26COVS1 or ChAdOx1-S results in a better immune response compared to a third dose of BNT162b2 or mRNA-1273 in kidney transplant recipients who did not develop an immune response following previous vaccination against COVID-19Intervention B - monoclonal SARS-CoV-2 antibody cocktail in kidney transplant recipients not responding to vaccination : Preventive strategies against SARS-CoV-2 in kidney transplant recipients:Intervention A – vaccination: Single blinded randomized controlled trial on BNT162b2 or mRNA-1273 (mRNA) vs Ad26COVS1 or ChAdOx1-S (viral vector) for third vaccination as well as pilot trial on fourth vaccination in kidney transplant recipients without SARS-CoV-2 spike protein antibodies following full vaccination against COVID-19 (BOOST-TX)Intervention B – monoclonal antibodies: Recombinant SARS-CoV-2-antibodies in kidney transplant recipients without neutralizing antibody response following full vaccination (RESCUE-TX)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Preventive strategies against SARS-CoV-2 in kidney transplant recipients:Intervention A - vaccination: Study to test if vaccination with Ad26COVS1 or ChAdOx1-S results in a better immune response compared to a third dose of BNT162b2 or mRNA-1273 in kidney transplant recipients who did not develop an immune response following previous vaccination against COVID-19Intervention B - monoclonal SARS-CoV-2 antibody cocktail in kidney transplant recipients not responding to vaccination : Preventive strategies against SARS-CoV-2 in kidney transplant recipients:Intervention A – vaccination: Single blinded randomized controlled trial on BNT162b2 or mRNA-1273 (mRNA) vs Ad26COVS1 or ChAdOx1-S (viral vector) for third vaccination as well as pilot trial on fourth vaccination in kidney transplant recipients without SARS-CoV-2 spike protein antibodies following full vaccination against COVID-19 (BOOST-TX)Intervention B – monoclonal antibodies: Recombinant SARS-CoV-2-antibodies in kidney transplant recipients without neutralizing antibody response following full vaccination (RESCUE-TX)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Antibody and cellular response 28 days after the first dose of COVID-19 vaccine (Moderna) and then 33 weeks after the second dose and 8-12 weeks after the third dose in clinically stable patients with functional kidney transplantation. : Antibody and cellular response 28 days after the first dose of COVID-19 vaccine (Moderna) and then 33 weeks after the second dose and 8-12 weeks after the third dose in clinically stable patients with functional kidney transplantation.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
Antibody and cellular response 28 days after the first dose of COVID-19 vaccine (Moderna) and then 33 weeks after the second dose and 8-12 weeks after the third dose in clinically stable patients with functional kidney transplantation. : Antibody and cellular response 28 days after the first dose of COVID-19 vaccine (Moderna) and then 33 weeks after the second dose and 8-12 weeks after the third dose in clinically stable patients with functional kidney transplantation.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
Study about the response to the administration of a third dose of mRNA-1273 vaccine (COVID19 vaccine Moderna) in renal transplants with immunological failure initial to vaccination : Study about the response to the administration of a third dose of mRNA-1273 vaccine (COVID19 vaccine Moderna) in renal transplants with immunological failure initial to vaccination
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
Study about the response to the administration of a third dose of mRNA-1273 vaccine (COVID19 vaccine Moderna) in renal transplants with immunological failure initial to vaccination : Study about the response to the administration of a third dose of mRNA-1273 vaccine (COVID19 vaccine Moderna) in renal transplants with immunological failure initial to vaccination
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Authorised-recruitment may be ongoing or finished
Medienart
16
Aufsätze
16
E-Artikel
16
E-Ressourcen
Zeitschriftentitel
16
WHO International Clinical Trials Registry Plat...
Thema
16
610
Recruitment Status: Authorised-recruitment may ...
16
Study Type: Interventional
10
Phase: Phase 4
6
Phase: Phase 2
2
Medical Condition: Antibody and cellular respon...
2
Medical Condition: COVID-19 is associated with ...
2
Medical Condition: COVID-19 is associated with ...
2
Medical Condition: COVID19 vaccine in kidney tr...
2
Medical Condition: Intervention A - vaccination...
2
Medical Condition: Kidney transplant patients;T...
2
Medical Condition: SARS-CoV-2 infection in Kidn...
2
Medical Condition: SARS-CoV-2 infection in kidn...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
6
2022
8
2021
2
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
16
Englisch
Haven't found what you're looking for?
Wird geladen...